Does dose matter? Effect of two different neoadjuvant protocols in advanced NSCLC - Steger, Volker; Veit, Stefanie; Walker, Tobias; Friedel, Godehard; Lehrach, Karoline; Mustafi, Migdat; Walles, Thorsten (The Thoracic and cardiovascular surgeon, 2013)
Keywords: Aged; Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Carcinoma, Non-Small-Cell Lung - mortality; Carcinoma, Non-Small-Cell Lung - pathology; Carcinoma, Non-Small-Cell Lung - therapy; Chemoradiotherapy, Adjuvant - adverse effects; Chemoradiotherapy, Adjuvant - mortality; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Lung Neoplasms - therapy; Male; Middle Aged; Neoadjuvant Therapy - adverse effects; Neoadjuvant Therapy - mortality; Neoplasm Staging; Pneumonectomy; Proportional Hazards Models; Radiation Dosage; Retrospective Studies; Time Factors; Treatment Outcome